Archive for October, 2012

ESM Technologies and Biova Announce Settlement of Patent Litigation

Carthage, Missouri, and Johnston, Iowa, USA; October 30, 2012 — ESM Technologies, LLC (“ESM”) and Biova, LLC (“Biova”) have resolved their differences and have agreed that each can continue to market and sell their respective current products. Biova does not believe U.S. Patent No. 6,946,551 (“the ‘551 Patent”) was properly construed, is valid or infringed, but, to forego the need for further litigation or an appeal and to resolve the matter fully between the parties, Biova agrees that the claims as construed by the District Court would have covered Biova’s process, and the ‘551 Patent is valid and enforceable.

Continue Reading

© 2017 Biova® LLC | Privacy Policy

* These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease.

** Details available upon request